Tela Bio Share Price (NASDAQ: TELA)

$1.78

▲

-0.02

(-1.11%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Tela Bio Stock chart to analyse performance

Tela Bio stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$1.73
Today's High:$1.78
$1.78
2.81%
Downside
Day's Volatility :2.81%
Upside
0.0%
52 Weeks Low:$0.86
52 Weeks High:$3.26
$1.78
51.43%
Downside
52 Weeks Volatility :73.48%
Upside
45.4%

Tela Bio Stock Returns

Period	Tela Bio Inc	Index (Russel 2000)
3 Months	23.94%	0.0%
6 Months	-24.79%	0.0%
1 Year	-36.23%	0.0%
3 Years	-78.67%	-4.7%

Tela Bio Inc Key Stats

Check Tela Bio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.8
Open	$1.73
Today's High	$1.78
Today's Low	$1.73
Market Capitalization	$71.3M
Today's Volume	$54.7K
52 Week High	$3.26
52 Week Low	$0.8645
Revenue TTM	$75.3M
EBITDA	$-36.2M
Earnings Per Share (EPS)	$-1.06
Profit Margin	-54.12%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-676.41%

Stock Returns calculator for Tela Bio Stock including INR - Dollar returns

The Tela Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Tela Bio investment value today

Current value as on today

₹66,663

Returns

₹33,337

(-33.34%)

Returns from Tela Bio Stock

₹38,621 (-38.62%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Tela Bio Stock

86%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Tela Bio Stock from India on INDmoney has increased by 86% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tela Bio Inc

Name
Holdings %
Name
Holdings %
Nantahala Capital Management, LLC
12.91%
Essex Woodlands Health Ventures
10.38%
SILVERARC CAPITAL MANAGEMENT, LLC
7.02%
Stonepine Capital Management Llc
5.26%
Vanguard Group Inc
4.83%
Dafna Capital Management LLC
3.64%

Analyst Recommendation on Tela Bio Stock

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Tela Bio(by analysts ranked 0 to 5 stars)

Tela Bio Share Price Target

What analysts predicted

Upside of 203.37%

Target:

$5.40

Current:

$1.78

Tela Bio share price target is $5.40, a slight Upside of 203.37% compared to current price of $1.78 as per analysts' prediction.

Tela Bio Stock Insights

Price Movement
In the last 1 month, TELA stock has moved down by -9.3%
Increasing Revenue
Revenue is up for the last 3 quarters, 17.64M → 20.19M (in $), with an average increase of 6.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -11.26M → -9.92M (in $), with an average increase of 13.5% per quarter
TELA vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 68.3%
TELA vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 242.8%
Price to Sales
ForTELA every $1 of sales, investors are willing to pay $0.9, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Tela Bio Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$15.4M	↑ 86.68%
Net Income	$-22.4M	↑ 6.32%
Net Profit Margin	-145.18%	↑ 109.74%

	FY20	Y/Y Change
Revenue	$18.2M	↑ 17.91%
Net Income	$-28.8M	↑ 28.4%
Net Profit Margin	-158.1%	↓ 12.92%

	FY21	Y/Y Change
Revenue	$29.5M	↑ 61.77%
Net Income	$-33.3M	↑ 15.57%
Net Profit Margin	-112.94%	↑ 45.16%

	FY22	Y/Y Change
Revenue	$41.4M	↑ 40.58%
Net Income	$-44.3M	↑ 33.24%
Net Profit Margin	-107.05%	↑ 5.89%

	FY23	Y/Y Change
Revenue	$58.5M	↑ 41.13%
Net Income	$-46.7M	↑ 5.25%
Net Profit Margin	-79.83%	↑ 27.22%

	FY24	Y/Y Change
Revenue	$69.3M	↑ 18.56%
Net Income	$-37.8M	↓ 18.91%
Net Profit Margin	-54.6%	↑ 25.23%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$16.6M	↓ 2.32%
Net Income	$-5.7M	↓ 56.08%
Net Profit Margin	-34.1%	↑ 41.73%

	Q2 FY24	Q/Q Change
Revenue	$16.1M	↓ 3.08%
Net Income	$-12.6M	↑ 122.58%
Net Profit Margin	-78.3%	↓ 44.2%

	Q3 FY24	Q/Q Change
Revenue	$19.0M	↑ 17.81%
Net Income	$-10.4M	↓ 17.68%
Net Profit Margin	-54.71%	↑ 23.59%

	Q4 FY24	Q/Q Change
Revenue	$17.6M	↓ 6.9%
Net Income	$-9.2M	↓ 11.22%
Net Profit Margin	-52.17%	↑ 2.54%

	Q1 FY25	Q/Q Change
Revenue	$18.5M	↑ 4.94%
Net Income	$-11.3M	↑ 22.33%
Net Profit Margin	-60.82%	↓ 8.65%

	Q2 FY25	Q/Q Change
Revenue	$20.2M	↑ 9.06%
Net Income	$-9.9M	↓ 11.91%
Net Profit Margin	-49.13%	↑ 11.69%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$9.3M	↑ 215.16%

	FY20	Y/Y Change
Profit	$11.2M	↑ 21.16%

	FY21	Y/Y Change
Profit	$18.8M	↑ 67.46%

	FY22	Y/Y Change
Profit	$27.0M	↑ 43.75%

	FY23	Y/Y Change
Profit	$40.1M	↑ 48.32%

	FY24	Y/Y Change
Profit	$46.5M	↑ 15.9%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$11.3M	↓ 2.48%

	Q2 FY24	Q/Q Change
Profit	$11.1M	↓ 2.32%

	Q3 FY24	Q/Q Change
Profit	$12.9M	↑ 16.12%

	Q4 FY24	Q/Q Change
Profit	$11.2M	↓ 12.73%

	Q1 FY25	Q/Q Change
Profit	$12.5M	↑ 11.51%

	Q2 FY25	Q/Q Change
Profit	$14.1M	↑ 12.73%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-25.5M	↑ 28.1%
Investing Cash Flow	$-12.0M	↑ 669.0%
Financing Cash Flow	$65.5M	↑ 139.05%

	FY20	Y/Y Change
Operating Cash Flow	$-24.5M	↓ 4.18%
Investing Cash Flow	$9.1M	↓ 176.14%
Financing Cash Flow	$44.4M	↓ 32.23%

	FY21	Y/Y Change
Operating Cash Flow	$-30.4M	↑ 24.44%
Investing Cash Flow	$-627.0K	↓ 106.87%
Financing Cash Flow	$585.0K	↓ 98.68%

	FY22	Y/Y Change
Operating Cash Flow	$-40.7M	↑ 33.9%
Investing Cash Flow	$-1.9M	↑ 198.56%
Financing Cash Flow	$40.9M	↑ 6883.25%

	FY23	Y/Y Change
Operating Cash Flow	$-40.9M	↑ 0.27%
Investing Cash Flow	$-599.0K	↓ 68.0%
Financing Cash Flow	$46.3M	↑ 13.26%

	FY24	Y/Y Change
Operating Cash Flow	$-41.6M	↑ 1.81%
Investing Cash Flow	$4.5M	↓ 843.07%
Financing Cash Flow	$43.1M	↓ 6.94%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-14.4M	↑ 30.16%
Investing Cash Flow	$4.7M	↓ 2533.16%
Financing Cash Flow	$56.0K	↑ 154.55%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-10.7M	↓ 25.63%
Investing Cash Flow	$67.0K	↓ 98.57%
Financing Cash Flow	$-5.0K	↓ 108.93%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-9.0M	↓ 16.02%
Investing Cash Flow	$-122.0K	↓ 282.09%
Financing Cash Flow	$98.0K	↓ 2060.0%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-7.5M	↓ 16.16%
Investing Cash Flow	$-190.0K	↑ 55.74%
Financing Cash Flow	$42.9M	↑ 43683.67%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-9.7M	↑ 29.13%
Investing Cash Flow	$138.0K	↓ 172.63%
Financing Cash Flow	$-116.0K	↓ 100.27%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-7.9M	↓ 18.71%
Investing Cash Flow	$204.0K	↑ 47.83%
Financing Cash Flow	$-3.0K	↓ 97.41%

Tela Bio Technicals Summary

Sell

Neutral

Buy

Tela Bio is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Tela Bio Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Tela Bio Inc	3.53%	-24.79%	-36.23%	-78.67%	-87.69%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Tela Bio Inc	NA	NA	NA	-0.83	-6.76	-0.36	NA	0.23
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Tela Bio Inc	Buy	$71.3M	-87.69%	NA	-54.12%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Tela Bio Inc

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Organization	Tela Bio
Employees	209
CEO	Mr. Antony Koblish
Industry	Health Technology

Key Management of Tela Bio Inc

Name	Title
Mr. Antony Koblish	Co-founder, CEO & Director
Mr. Jeffrey Blizard	President of TELA Bio & Director
Mr. Roberto E. Cuca J.D.	CFO & COO
Mr. Paul Talmo	Chief Technology Officer
Ms. Megan Smeykal	VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer
Mr. D. Taylor Ocasio	General Counsel & Corporate Secretary
Ms. Jennifer Lou Armstrong	Senior Vice President of Human Resources
Mr. Gregory A. Firestone	Chief Commercial Officer
Mr. Michael Leonard	Senior Vice President of Technical Operations
Mr. Peter C. Murphy	Chief Commercial Officer

Important FAQs about investing in TELA Stock from India :

What is Tela Bio share price today?

Tela Bio share price today is $1.78 as on August 30, 2025 at 1:29 am IST at the close of the market. Tela Bio share today touched a day high of $1.78 and a low of $1.73.

What is the 52 week high and 52 week low for Tela Bio share?

Tela Bio share touched a 52 week high of $3.26 and a 52 week low of $0.86. Tela Bio stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $1.78, lower by 45.4% versus the 52 week high.

How to invest in Tela Bio Stock (TELA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tela Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tela Bio Shares that will get you 0.8427 shares as per Tela Bio share price of $1.78 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tela Bio Stock (TELA) from India?

Indian investors can start investing in Tela Bio (TELA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Tela Bio stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Tela Bio share’s latest price of $1.78 as on August 30, 2025 at 1:29 am IST, you will get 5.6180 shares of Tela Bio. Learn more about fractional shares .

What are the returns that Tela Bio has given to Indian investors in the last 5 years?

Tela Bio stock has given -87.69% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?